GynEC®-DX at the 33rd meeting of the SEGO Gynecologic Oncology section

The SEGO endometrial cancer guide, which describes the protocol recommended by specialists for the diagnosis of this disease, alludes, for the first time, to the availability of the first commercially available molecular diagnostic test to rule out this type of cancer. This was highlighted during the National Congress of the Oncology Section of the Spanish Society of Gynecology and Obstetrics (SEGO) held recently in San Sebastián.

See related news